CitraFlow® 4% SF

Anticoagulant solution in pre-filled syringes for sealing or rinsing central venous catheters.

CitraFlow has proven its effectiveness and safety time and time again, millions of times over the last 10 years of hemodialysis use.

A clinically proven alternative to work in some of the most demanding clinical situations; in hemodialysis catheter sealing procedures.

Description

Anticoagulant solution in pre-filled syringes for sealing or rinsing central venous catheters.

Clinical studies have shown that the use of a 4% sodium citrate anticoagulant solution for sealing or rinsing central venous catheters has significant advantages compared to existing standards of care.

The current standard of sealing or rinsing for intraluminal catheter treatment care is “deficient” as the only two products used for catheter sealing and rinsing are saline and heparin.

There is now a clinically proven alternative to work in some of the most demanding clinical situations; in hemodialysis catheter sealing procedures. CitraFlow has proven its effectiveness and safety time and time again, millions of times over the last 10 years of hemodialysis use.

SAFER THAN HEPARIN

  • Avoids the risk of systemic heparinization.
  • Prevents exacerbation of active bleeding.
  • Safe for use in patients with HIT (heparin-induced thrombocytopenia).
  • Greater reliability INR (International Normalized Ratio).
  • Recommended by ERBP and ASDIN standards.
  • Terminally sterilized. Product compatible with the sterile field.Available in a safe and convenient form for blister use with two 5 ml syringes pre-filled with 3 ml of citrate each.
  • All natural. No artificial colors, no preservatives.
  • No side effects.

 

MORE EFFECTIVE THAN SALINE SOLUTION

  • Reduction of coagulation incidents.
  • Lower percentages of tPA utilization and costs.
  • Reduction of catheter change percentages.
  • Prevents the formation of biofilms.
  • The percentage of catheter-related bacteremia infections decreases.
  • Potential savings compared to other sealing treatment regimens.
  • Reduction of hospitalization.

 

* This product may or may not be available in a particular country, and if so, may not have been approved or authorized for marketing by different indications and restrictions of government regulations in different countries. | Representative photo only. The product may not be exactly as shown.